Although association of homozygous (ZZ) deficiency of alpha,-antitrypsin (AAT) with premature pulmonary emphysema, especially in cigarette smokers, is well established,' the role of heterozygous AAT deficiency in this context has been controversial. Lieberman and his coworkers2 recently reported further evidence supporting their earlier data3 which indicated that heterozygous AAT deficiency was significantly more common in COPD patients than in the control population. I AAT levels were determined initially by serum tryptic inhibitory capacity (STIC) and subsequently-in most cases-by radial immunodiffusion. This was combined with acid starch gel electrophoresis typing and family studies later in the study The initiallydetected patients thought to have abnormal phenotypes by the STIC method were, in most cases, confirmed by the later methods and/or by family studies. It is possible that the STIC method underestimated the number of MS and MZ patients. Table 1 shows the frequency of the AAT phenotypes in our study in 190 emphysema patients and 1,303 caucasian control subjects4 and similar data from Lieberman et al.2 In both studies the MS variant frequency may have been underestimated in patients, but obviously was not dramatically different from control subjects. In contrast, in both studies the MZ frequency was over three times higher in patients than in control subjects. Thus in New Zealand, 14.2 percent of emphysema patients and 3.9 percent of control subjects were phenotype MZ (or FZ, p<0.0005), and in the US 8.0 percent of COPD patients were MZ (or in a few cases SZ) compared with 2.9 percent of control subjects, (p<0.0005). Among MZ heterozygotes with emphysema, cigarette smoking exposure was usually in the range of 15 to 75 pack-years. Frequency of the ZZ phenotype was 2.6 percent in New Zealand and 1.9 percent in the US studies, markedly higher than the population frequency but still accounting for only a small proportion of all emphysemaJCOPD patients. In homozygous patients, onset of symptoms occurs at an earlier age and after a lesser amount of cigarette exposure. ' Although the predisposition to emphysema does not appear to be evident when looking at lung function in intermediate deficiency in general populations,5 our results support the conclusion of Lieberman et a12 that in COPD patients (particularly emphysema patients) there is an increase in the frequency of Pi types that produce intermediate degrees of AAT deficiency (especially MZ), and the viewpoint that this deficiency enhances the detrimental effect of cigarette smoking on the lungs. 
length, with a maximum offive references; onefigure or table can be printed. Exceptions may occur under particular circumstances. Contributions may include comments on articles published in this periodical, or they may be reports ofunique educational character. Specific permission to publish should be cited in a covering letter or appended as a postscript.
Alpha1-antitrypsin Pi Types in COPD Patients
To the Editor:
Although association of homozygous (ZZ) deficiency of alpha,-antitrypsin (AAT) with premature pulmonary emphysema, especially in cigarette smokers, is well established,' the role of heterozygous AAT deficiency in this context has been controversial. Lieberman and his coworkers2 recently reported further evidence supporting their earlier data3 which indicated that heterozygous AAT deficiency was significantly more common in COPD patients than in the control population. I AAT levels were determined initially by serum tryptic inhibitory capacity (STIC) and subsequently-in most cases-by radial immunodiffusion. This was combined with acid starch gel electrophoresis typing and family studies later in the study The initiallydetected patients thought to have abnormal phenotypes by the STIC method were, in most cases, confirmed by the later methods and/or by family studies. It is possible that the STIC method underestimated the number of MS and MZ patients. Table 1 shows the frequency of the AAT phenotypes in our study in 190 emphysema patients and 1,303 caucasian control subjects4 and similar data from Lieberman et al. 2 In both studies the MS variant frequency may have been underestimated in patients, but obviously was not dramatically different from control subjects. In contrast, in both studies the MZ frequency was over three times higher in patients than in control subjects. Thus in New Zealand, 14.2 percent of emphysema patients and 3.9 percent of control subjects were phenotype MZ (or FZ, p<0.0005), and in the US 8.0 percent of COPD patients were MZ (or in a few cases SZ) compared with 2.9 percent of control subjects, (p<0.0005). Among MZ heterozygotes with emphysema, cigarette smoking exposure was usually in the range of 15 to 75 pack-years. Frequency of the ZZ phenotype was 2.6 percent in New Zealand and 1.9 percent in the US studies, markedly higher than the population frequency but still accounting for only a small proportion of all emphysemaJCOPD patients. In homozygous patients, onset of symptoms occurs at an earlier age and after a lesser amount of cigarette exposure. ' Although the predisposition to emphysema does not appear to be evident when looking at lung function in intermediate deficiency in general populations,5 our results support the conclusion of Lieberman et a12 that in COPD patients (particularly emphysema patients) there is an increase in the frequency of Pi types that produce intermediate degrees of AAT deficiency (especially MZ), and the viewpoint that this deficiency enhances the detrimental effect of cigarette smoking on the lungs. We read with interest the article by Farman and Speirl in which they stated that atypical roentgenographic presentation of lung tuberculosis is still uncommon in adults. This is in contrast with other studies2-5 in which an increased frequency of unusual presentations similar to those in childhood are described (especially in older patients) and are attributed to the fact that these patients have outlived their initial infecting mycobacteria and become more susceptible to exogenous reinfection.
We reviewed the chest x-ray films from 114 adult patients with bacteriologically-proven lung tuberculosis diagnosed between 1981 and 1985. We made a subdivision between "usual postprimary tuberculosis" consisting of infiltrations (with or without cavitation) in the apicoposterior segments of the upper and/or lower lobes whether or not these were associated with other lesions, and "unusual" localisations without even minor inactive sequellae in the apicoposterior zones on tomographs (Table) . We found no difference in presentation between patients younger vs older than 60 years of age (Table) . Our findings were in agreement with those of Farman and Speirl and Hadlock et al,6 but in contrast with others. 24 We conclude that, in our country, endogeneous reactivations remain the main pathogenic pathway in the elderly The difference between the published studies may at least partly be attributed to sometimes arbitrary differences in classification as usual or unusual form. We therefore agree with Kovnat7 that the importance of a uniform classification should be stressed. Verea Hernando et all have reported that a ratio of the lysozyme level in the pleural fluid to that in the serum (PL/SL ratio) higher than 1.2 strongly suggests a diagnosis oftuberculosis when empyema has been excluded. They indicated that, at the present time, no conclusion could be drawn concerning an effusion due to a collagen disease.
Since this article appeared, we found a false-positive result in a 56-year-old woman suffering from rheumatoid arthritis for 20 years; she presented with dyspnea due to a large, right-sided pleural effusion. On [PMN] , many of them undergoing lytic changes). Typically, glycopleuria was very low (3 mg/dl) and didn't increase up to 180 min after a 25 g intravenous charge of glucose; rheumatoid factor was weakly positive; lactic acid was 10.6 mmol/L (1.1) and pH 7.03. Lysozyme determined by a turbidimetric spectrophotometric method2 was 29.5 mg/dl in the pleural fluid, against 9.0 in the serum (PL/SL ratio 3.3). Bacteriologic study was negative, as were three specimens taken for Ziehl stain and Loewenstein culture.
Cytologic examination was negative for malignant cells, but the CEA level was high (14.4 ng/ml vs 0.4 in the serum); this prompted us to carry out thoracoscopy. Parietal pleura appeared diffusely inflamed, with a finely granulous aspect in its lower part. Several biopsy specimens showed a mild mononuclear infiltration covered by strongly hyperplastic mesothelium.
This patient thus presented with features of rheumatoid pleurisy without any sign of tuberculosis; her PL/SL ratio was 3.3, well above the cutoff point and highly suggestive of a mycobacterial origin.
In a series by Klockars and Petterson,3 three of 13 patients with rheumatoid effusion also had a PL/SL ratio higher than 1 
